These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15663328)

  • 1. Bacteria in the treatment of cancer.
    Lin J; Lin E; Nemunaitis J
    Curr Opin Mol Ther; 2004 Dec; 6(6):629-39. PubMed ID: 15663328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial targeted tumour therapy-dawn of a new era.
    Wei MQ; Mengesha A; Good D; Anné J
    Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bacteria in anti-cancer therapies.
    Ryan RM; Green J; Lewis CE
    Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial vectors and delivery systems in cancer therapy.
    Gardlik R; Fruehauf JH
    IDrugs; 2010 Oct; 13(10):701-6. PubMed ID: 20878592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bacterial vectors for tumor-targeted gene therapy.
    Jia LJ; Hua ZC
    Methods Mol Biol; 2009; 542():131-54. PubMed ID: 19565900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for cancer: dairy bacteria as delivery vectors.
    Tangney M
    Discov Med; 2010 Sep; 10(52):195-200. PubMed ID: 20875340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial gene therapy strategies.
    Vassaux G; Nitcheu J; Jezzard S; Lemoine NR
    J Pathol; 2006 Jan; 208(2):290-8. PubMed ID: 16362987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
    Sinkovics JG; Horvath JC
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral strategies for the gene therapy of cancer.
    Relph KL; Harrington KJ; Pandha H
    Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
    Gardlik R; Behuliak M; Palffy R; Celec P; Li CJ
    Gene Ther; 2011 May; 18(5):425-31. PubMed ID: 21228886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
    Bauzon M; Hermiston TW
    Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.
    Morille M; Passirani C; Vonarbourg A; Clavreul A; Benoit JP
    Biomaterials; 2008; 29(24-25):3477-96. PubMed ID: 18499247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
    Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
    Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteria in gene therapy: bactofection versus alternative gene therapy.
    Pálffy R; Gardlík R; Hodosy J; Behuliak M; Resko P; Radvánský J; Celec P
    Gene Ther; 2006 Jan; 13(2):101-5. PubMed ID: 16163379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
    Vorhies JS; Nemunaitis J
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):373-82. PubMed ID: 17338656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials.
    Clark JR; March JB
    Trends Biotechnol; 2006 May; 24(5):212-8. PubMed ID: 16567009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
    Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
    Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
    Palmer DH; Chen MJ; Searle PF; Kerr DJ; Young LS
    Gene Ther; 2005 Aug; 12(15):1187-97. PubMed ID: 15800660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.